- Home
- EKSO vs ALLR Comparison
EKSO vs ALLR Comparison
Compare EKSO & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EKSO
- ALLR
- Stock Information
- Founded
- EKSO 2005
- ALLR 2004
- Country
- EKSO United States
- ALLR United States
- Employees
- EKSO N/A
- ALLR N/A
- Industry
- EKSO Medical/Dental Instruments
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- EKSO Health Care
- ALLR Health Care
- Exchange
- EKSO Nasdaq
- ALLR Nasdaq
- Market Cap
- EKSO 11.7M
- ALLR 13.3M
- IPO Year
- EKSO N/A
- ALLR N/A
- Fundamental
- Price
- EKSO $2.82
- ALLR $0.90
- Analyst Decision
- EKSO Strong Buy
- ALLR
- Analyst Count
- EKSO 2
- ALLR 0
- Target Price
- EKSO $37.50
- ALLR N/A
- AVG Volume (30 Days)
- EKSO 238.2K
- ALLR 448.4K
- Earning Date
- EKSO 07-28-2025
- ALLR 08-04-2025
- Dividend Yield
- EKSO N/A
- ALLR N/A
- EPS Growth
- EKSO N/A
- ALLR N/A
- EPS
- EKSO N/A
- ALLR N/A
- Revenue
- EKSO $17,544,000.00
- ALLR N/A
- Revenue This Year
- EKSO $0.20
- ALLR N/A
- Revenue Next Year
- EKSO $42.29
- ALLR N/A
- P/E Ratio
- EKSO N/A
- ALLR N/A
- Revenue Growth
- EKSO N/A
- ALLR N/A
- 52 Week Low
- EKSO $2.82
- ALLR $0.61
- 52 Week High
- EKSO $22.95
- ALLR $10.59
- Technical
- Relative Strength Index (RSI)
- EKSO 20.84
- ALLR 48.97
- Support Level
- EKSO $3.75
- ALLR $0.80
- Resistance Level
- EKSO $4.03
- ALLR $0.98
- Average True Range (ATR)
- EKSO 0.35
- ALLR 0.06
- MACD
- EKSO -0.07
- ALLR 0.01
- Stochastic Oscillator
- EKSO 0.00
- ALLR 59.39
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.